HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is expected to drive growth of the HIV-associated lipodystrophy treatment market
Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1269
Increasing prevalence of HIV is expected to drive growth of the HIV-associated lipodystrophy treatment market
According to an article published in Journal of AIDS & Clinical Research in 2014, prevalence of lipodystrophy in patients suffering from HIV varies significantly and was estimated between 32.4% and 88.6%. According to World Health Organization (WHO) in 2017, more than 35 million people are suffering from HIV worldwide and an estimated 1.0 million people died from HIV in 2016. Increasing prevalence of HIV is expected to drive growth of the HIV-associated lipodystrophy market as most (32.4-88.6%) of the people suffering from HIV also suffer from HIV-associated lipodystrophy.
Approval of novel drugs in key regions such as North America is expected to drive the growth of HIV-Associated Lipodystrophy Market. For instance, in 2014, Theratechnologies Inc. received approval from Health Canada for its EGRIFTA. It is a growth hormone-releasing factor (GRF) for the treatment of HIV-associated lipodystrophy. EGRIFTA had also received the U.S. Food and Drug Administration (FDA) approval in 2010. Such approval of new drugs in the key region is expected to drive growth of the HIV-associated lipodystrophy treatment market.
Global HIV-Associated Lipodystrophy Treatment Market Taxonomy
The global HIV-associated lipodystrophy treatment market is segmented on the basis of lipodystrophy type, therapeutic class, and distribution channel.
On the basis of lipodystrophy type, the global HIV-associated lipodystrophy treatment market is segmented into:
On the basis of therapeutic class, the global HIV-associated lipodystrophy treatment market is segmented into:
Insulin resistance modulators
Mitochondrial antioxidants (l-carnitine)
Other miscellaneous metabolic agents
On the basis of the distribution channel, the global HIV-associated lipodystrophy treatment market is segmented into:
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is expected to drive growth of the HIV-associated lipodystrophy treatment market here
News-ID: 2434169 • Views: 537
More Releases from Coherent Market Insights
Recurrent Glioblastoma Multiforme Treatment Market Expected to Expand at a Stead …
The Recurrent Glioblastoma Multiforme Treatment Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Recurrent glioblastoma multiforme is an aggressive type of brain tumor that recurs after initial treatment. Treatment options for recurrent glioblastoma include surgical resection, radiotherapy, chemotherapy and targeted drug therapy. Market Dynamics: The recurrent glioblastoma multiforme treatment market is driven by increasing product approvals for treatment of
Knee Braces Market Booming Growth in Future Scope 2023-2030 | Alex Orthopedic In …
The Knee Braces Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Knee braces provide support and stability to knees. They are used for injuries like ligament tears, cartilage damage, arthritis etc. Sportspersons also use knee braces for injury prevention. Market Dynamics: According to the National Center for Biotechnology Information, over 250,000 Americans undergo knee replacement surgery each year owing
Automotive Aluminum Market Size, Share - 2023, Key Driving Factors for Growing C …
Market Overview: Automotive aluminum is a lightweight metal extensively used in the automotive sector for various applications ranging from powertrain, closure parts, interior & exterior trims to wheels. Aluminum allows automakers to achieve lighter vehicle weights and improve fuel efficiency. Market Dynamics: The automotive aluminum market is driven by the increasing demand for lightweight materials from automakers to meet stringent emission norms. Aluminum helps reduce the overall weight of the vehicles, thereby enhancing
Gamma Knife Market Will Generate Booming Growth Opportunities to 2030 | Elekta, …
The Gamma Knife Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Gamma Knives are specialized devices used for non-invasive neurosurgery to treat tumors and other brain lesions using beams of high-energy radiation concentrated in three dimensions. It has the advantage of treating multiple brain metastases and disorders in a single session. Market Dynamics: The Gamma Knife market is expected
More Releases for HIV
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral
Approaches to HIV Eradication
The various approaches to HIV eradication all address a problem, and that problem is the HIV reservoir. HIV reservoirs have been called the last hiding place for HIV within the body. The final step toward finding a cure against HIV lies in dealing with HIV reservoirs. Toulon, France, August 30, 2011 - What can be done about HIV eradication? The advancements in scientific technology and medical treatments have made significant progress